Accessibility Menu
 
Novo Integrated Sciences logo

Novo Integrated Sciences

(OTC) NVOS

Current Price$0.00
Market Cap$61,200
Since IPO (2017)-100%
5 Year-100%
1 Year+288%
1 Month+0%

Novo Integrated Sciences Financials at a Glance

Market Cap

$61,200

Revenue (TTM)

$13.29M

Net Income (TTM)

$16.17M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-7.77 (Low)

Price

$0.00

Volume

439

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.06

NVOS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novo Integrated Sciences

Industry

Healthcare Providers and Services

Employees

264

CEO

Robert Mattacchione

Headquarters

Bellevue, WA 98004, US

NVOS Financials

Key Financial Metrics (TTM)

Gross Margin

43%

Operating Margin

-63%

Net Income Margin

-1%

Return on Equity

0%

Return on Capital

-47%

Return on Assets

-50%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$61.20K

Shares Outstanding

19.73M

Volume

439

Avg. Volume

2.37K

Financials (TTM)

Gross Profit

$5.74M

Operating Income

$8.31M

EBITDA

$10.08M

Operating Cash Flow

$2.24M

Capital Expenditure

$49.22K

Free Cash Flow

$2.29M

Cash & ST Invst.

$844.58K

Total Debt

$4.71M

Novo Integrated Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$3.08M

-6.7%

Gross Profit

$1.58M

+70.0%

Gross Margin

51.21%

N/A

Market Cap

$61.20K

N/A

Market Cap/Employee

$532.17

N/A

Employees

115

N/A

Net Income

$5.00M

+258.3%

EBITDA

$7.25M

+440.7%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Net Cash

$3.87M

+4.7%

Accounts Receivable

$3.15M

+114.9%

Inventory

$1.00M

-9.6%

Long Term Debt

$2.99M

+70.2%

Short Term Debt

$3.16M

+16.4%

Return on Assets

-50.18%

N/A

Return on Invested Capital

-47.34%

N/A

Free Cash Flow

$548.95K

-111.8%

Operating Cash Flow

$545.92K

-138.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PBLAPanbela Therapeutics, Inc.
$0.01+0.00%
OMHEOmni Health, Inc.
$0.00+0.00%
BRAXFBraxia Scientific Corp.
$0.00+0.00%
BBBTBlack Bird Biotech, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CNSPCns Pharmaceuticals
$9.14+2.95%
GBTGGlobal Business Travel Group
$9.35+0.58%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.11+0.00%
SOUNSoundHound AI
$9.77+0.02%

Questions About NVOS

What is the current price of Novo Integrated Sciences?

Novo Integrated Sciences is trading at $0.00 per share.

What is the 52-week range for Novo Integrated Sciences?

Over the past 52 weeks, Novo Integrated Sciences has traded between $0.00 and $0.06.

How much debt does Novo Integrated Sciences have?

As of the most recent reporting period, Novo Integrated Sciences reported total debt of $5.98M.

How much cash does Novo Integrated Sciences have on hand?

Novo Integrated Sciences reported $844,584 in cash and cash equivalents in its most recent financial results.

What is Novo Integrated Sciences’s dividend yield?

Novo Integrated Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.